Targeted Precision Oncology: Insights into the PARP Inhibitors Market

a adăugat un sunet Health

2025-09-17 17:53:36

PARP Inhibitors Market Overview and Therapeutic Importance Poly (ADP-ribose) polymerase (PARP) inhibitors have become a foundational tool in precision oncology, particularly for cancers with DNA repair deficiencies. By exploiting synthetic lethality in tumors with homologous recombination deficiency (HRD), especially those harboring BRCA1/2 mutations, these agents extend beyond initial...

0 Commentarii 0 Distribuiri 615 Views 0 previzualizare